Oneness Biotech Co Ltd

Oneness Biotech Co., Ltd. is a Taiwan-based company engaged in the research, development, and sale of new drugs, pharmaceuticals, and health products. It operates through two segments: New Drug Research and Development, and Agricultural Products Cultivation and Organic Food. The company offers Fespixon for diabetic foot ulcers and Bonvadis, a wound care medical device. Its pipeline includes FB825 in Phase II trials for atopic dermatitis and allergic asthma, FB704A in Phase II trials for rheumatoid arthritis and tumor angiogenesis inhibition, SNS812 in Phase II trials for COVID, and SNS851 in clinical development for metabolic diseases such as obesity, diabetes, hypercholesterolemia, and fatty liver disease. It also manages agricultural cultivation and organic food trading, and sells organic food, dietary supplements, and beverages. Incorporated in 2008, it is headquartered in Taipei, Taiwan.